Skip to main content

Table 1 The mRNA expressions of glucose metabolic markers in three EMT types of CTCs (Cohort 1a)

From: Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

Target probe Positive/ total CTCs Positive/Negative in 3 types χ2 P
E-CTCs H-CTCs M-CTCs
HK2 4/25 (0.16) 0/9 4/4 0/8 7.595 0.011*
PDP2 30/39 (0.77) 4/2 21/2 5/5 7.045 0.030*
G6PD 37/50 (0.74) 2/0 25/1 10/12 16.41 0.001*
PGK1 25/61 (0.41) 1/6 15/26 9/4 6.929 0.031*
PHKA1 28/42 (0.67) 7/4 17/2 4/8 10.98 0.004*
PYGL 44/59 (0.75) 5/5 27/8 12/2 3.925 0.141
PDK1 45/70 (0.64) 5/9 23/11 17/5 6.761 0.034*
PKM2 68/90 (0.76) 16/2 36/4 16/16 17.18 0.001*
  1. *P < 0.05
  2. aCohort 1 includes 64 patients pathologically diagnosed with common cancer